Safety of rituximab in children with auto-immune diseases 由 Bader-Meunier B, Quartier P, Wouters C

Juvenile idiopathic arthritis with dry synovitis: clinical and imaging aspects in a cohort of 6 patients 由 Bader-Meunier B, Wouters C, Lambot K, De Somer L

Pediatric systemic lupus erythematosus and human parvovirus B19 infection 由 Quartier P, Salomon R, Sauvion S, Bélien-Pallet V, Bader-Meunier B

Diversity in clinical manifestations of autoinflammatory syndromes 由 Bader-Meunier B, Mouy R, Compeyrot-Lacassagne S, Neven B, Boiu S, Quartier P

Is there any relationship between the exposure to mycophenolic acid and the clinical status in children with lupus? 由 Fischbac M, Bérard E, Decramer S, Ranchin B, Bader-Meunier B, Jurado C, Saint-Marcoux F

Inflammatory arthritis associated with inflammatory bowel disease in children 由 Desgranges M, Ruemmele FM, Duquesnes A, Ginies JL, Goulet O, Quartier P, Bader-Meunier B

Cytophagic histiocytic panniculitis: is it a macrophage activation syndrome in situ? 由 Brousse N, Brochard K, de Saint Basile G, Janssen CEI, Fraitag S, Bader-Meunier B, Bodemer C, Wouters C

2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic J... 由 Ruperto N, Quartier P, Wulffraat N, Woo P, Loy A, Mouy R, Bader-Meunier B, Prakken B, Noseda E, Rordorf C

Dosing patterns of canakinumab in patients with Cryopyrin-Associated Periodic Syndromes (CAPS): A comparative analysis of a study in Western versus Japanese patients 由 Takada H, Nishikomori R, Imagawa T, Lheritier K, Preiss R, Patel N, Gattorno M, Kuemmerle-Deschner J, Hachulla P, Bader-Meunier B, Heike T, Hara T, Yokota S

International PFAPA syndrome registry: cohort of 214 patients 由 Hofer MF, Pillet P, Berg S, Brik R, Dolezalova P, Kone-Paut I, Anton J, Touitou I, Bader-Meunier B, Kaiser D, Rigante D, Duquesne A, Wouters C, Gattorno M

Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations. 由 Rieux-Laucat, F, Blachère, S, Danielan, S, De Villartay, J, Oleastro, M, Solary, E, Bader-Meunier, B, Arkwright, P, Pondaré, C, Bernaudin, F, Chapel, H, Nielsen, S, Berrah, M, Fischer, A, Le Deist, F

Creation of a cohort of French patients with chronic recurrent multifocal osteitis : preliminary results 由 Lemelle I, Duquesne A, Despert V, Jean S, Desjonquères M, Wouters C, Mouy R, Bader-Meunier B, Lacassagne S, Faye A, Kettani S, Lorrot M, Dumitrescu MA, Wipff J, Pillet P, Grall-Lerosey M, Quartier P, Job-Deslandre C

Janus kinase inhibition for autoinflammation in DNASE2 deficiency 由 Hong, Y, Capitani, M, Murphy, C, Pandey, S, Cavounidis, A, Takeshita, H, Nanthapisal, S, Yasuda, T, Bader-Meunier, B, McCreary, D, Omoyinmi, E, Rao, A, Booth, C, Gilmour, K, Sebire, N, Shah, N, Klein, N, Bullock, A, Eleftheriou, D, Uhlig, H, Brogan, P